Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(186 intermediate revisions by 10 users not shown)
Line 1: Line 1:
Welcome! 


*For assignments, please see the "Author" column below.  If no name is present, volunteer to create content!
*We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books.  '''<u>If there is an entity not yet listed below that you would like to author in any WHO book, we would be happy to create a page for you now</u>'''.
*To volunteer, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your page of interest.
*'''<u>NOTE: A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated by late-2023; we're working on a plan to align the related CCGA content to the new structure.</u>'''
__TOC__
==WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content==
{| class="wikitable"
{| class="wikitable"
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
Line 25: Line 17:
|
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|Date page was created
|
|
|
|-
|-
Line 35: Line 27:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 45: Line 37:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 69: Line 61:
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|
|
|complete
|complete/pending faculty review
|
|
|FQR
|FQR
Line 79: Line 71:
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Chelsea D. Kramish (trainee), Daynna J.Wolff
|(trainee), Daynna J.Wolff
|
|
|
|
|complete/pending faculty review
|pending faculty review
|
|
|FQR
|FQR
Line 90: Line 82:
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|Thomas Lee
|
|8/17/2020
|
|9/7/2020
|complete
|complete
|
|
Line 98: Line 90:
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||Shashi Shetty, Ph.D.
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|
|
Line 107: Line 99:
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung + Shuo-Shawn Liu (trainee)
|Thuy Phung/Shuo-Shawn Liu
|
|
|
|
|complete
|complete/pending adding content online as of 2/4/21
|
|
|FQR
|FQR
Line 127: Line 119:
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung +Jordan Lowery (trainee)
|Thuy Phung +Jordan Lowery
|
|
|
|
Line 183: Line 175:
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|
|
Line 194: Line 186:
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|
|
Line 233: Line 225:
|
|
|9/1/20
|9/1/20
|PENDING importing content and reference formatting
|PENDING
|
|
|FQR
|FQR
|
|
|FQR has emailed SR several times, last 4/20/22
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
Line 245: Line 237:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 257: Line 249:
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Jack Reid (trainee)+Fabiola Quintero-Rivera
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|
|4/21/22
|9/1/20
|pending
|pending
|
|
Line 295: Line 287:
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 305: Line 297:
|
|
|9/1/20
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 332: Line 324:
|
|
|9/1/20
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 338: Line 330:
|
|
|-
|-
|Myelodysplastic Neoplasm with Biallelic TP53 Inactivation
| || ||
|Disease
|
|Eric McGinnis
|
|
| ||
|
|
|5/4/23
|PENDING
| ||FQR
|
|
|'''Page New in 5th Edition of Book'''. 2021 template added.
|-
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
Line 368: Line 358:
|
|
|
|
|''<s>PENDING</s> Complete - awaiting clarification''
|PENDING
| ||JH / MS
| ||JH / MS
|04/26/2021 -MS (re-review)
|04/26/2021 -MS (re-review)
|Review completed, awaiting some clarification from JH - 07/04/2022
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
Line 478: Line 468:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
Corboy (Monash Health)
|
|
|
|
Line 487: Line 476:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
Line 495: Line 484:
|Add WHO reference
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Corboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|
|
Line 713: Line 702:
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Disease
|Kay Weng Choy + Greg Corboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
Line 756: Line 745:
|
|
|
|
| ||Holli Drendel (HD)
| ||Yassmine Akkari (YA)
|
|
|
|YA (prior AE)
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
Line 764: Line 753:
|
|
|
|
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain (trainee) + Yassmine Akkari
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
Line 781: Line 770:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
Line 789: Line 778:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
Line 797: Line 786:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
Line 808: Line 797:
|Complete
|Complete
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
Line 816: Line 805:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
Line 824: Line 813:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
Line 833: Line 822:
|Complete
|Complete
|
|
|HD
|YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|
|
|Complete
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
Line 849: Line 838:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
Line 860: Line 849:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
Line 871: Line 860:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
Line 882: Line 871:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
Line 893: Line 882:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
Line 904: Line 893:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
Line 915: Line 904:
|PENDING
|PENDING
|
|
|HD
|YA
|
|
|YA (prior AE); NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
Line 923: Line 912:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE)
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
Line 931: Line 920:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE); 2021 template added
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
Line 939: Line 928:
|
|
|PENDING
|PENDING
| ||HD
| ||YA
|
|
|
|YA (prior AE); 2021 template added
|-
|-
| || ||
| || ||
Line 955: Line 944:
|
|
|
|
| ||Shivani Golem (SG)
| ||Snehal Patel (SP)
|
|
|
|SP (prior AE)
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Jaime Nagy, PhD/
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
 
|
Renee Eigsti, MD
|
|
|
|
|
|PENDING
|SP
|
|
|SG
|
|
|SP (prior AE); NOTE TO BAILEY: author updating page on staging server with conversion to new template (small amount of content on older template with 4th edition content - need to convert to new template and update to 5th edition content). Then transfer to production server when ready.
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Tsigab Bahta Hagos (trainee) / Shashirekha Shetty
|       Monoclonal B-cell  Lymphocytosis||Disease||
|12/19/2022
|
|1/19/2023
|
|PENDING
|
|
|SP
|
|
|SG
|
|
|SP (prior AE), 2021 template added
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||
|B-cell Prolymphocytic Leukemia||Disease||
Line 984: Line 971:
|
|
|
|
|SG
|SP
|
|
|
|SP (prior AE); 2021 template added; No longer an entity
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
Line 993: Line 980:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|Hairy Cell Leukemia||Disease||Snehal Patel
Line 1,002: Line 989:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
Line 1,011: Line 998:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
Line 1,020: Line 1,007:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
Line 1,029: Line 1,016:
|Complete
|Complete
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|Complete
|
|
|SG
|
|4/12/2023 by FQR
|SP
|SP (prior AE); 2021 template added
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|
|
|Complete
|
|
|SG
|
|4/12/2023 by FQR
|SP
|SP (prior AE); 2021 template added
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
Line 1,055: Line 1,042:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
Line 1,063: Line 1,050:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|    Mu Heavy Chain  Disease||Disease||
|    Mu Heavy Chain  Disease||Disease||
Line 1,071: Line 1,058:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
Line 1,079: Line 1,066:
|
|
|Complete
|Complete
|5/26/2021||SG
|5/26/2021||SP
|
|
|
|SP (prior AE)
|-
|-
|    Alpha Heavy Chain  Disease||Disease||
|    Alpha Heavy Chain  Disease||Disease||
Line 1,087: Line 1,074:
|
|
|
|
| ||SG
| ||SP
|
|
|
|SP (prior AE)
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
Line 1,096: Line 1,083:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
Line 1,105: Line 1,092:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
Line 1,114: Line 1,101:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
Line 1,123: Line 1,110:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Plasmacytoma||Disease||Zhenya Tang
|    Plasmacytoma||Disease||Zhenya Tang
Line 1,132: Line 1,119:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||Chen Yang, MD, PhD
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
|Complete
|09/10/2022||SG
|
|
|SP (prior AE)
| ||SP
|
|
|-
|-
|           Primary  Amyloidosis||Disease||Heather E. Williams, PhD
|           Primary  Amyloidosis||Disease||
|
|
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
| ||SP
|
|
|-
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease||Chen Yang, MD, PhD
|           Light Chain and Heavy Chain Deposition Disease||Disease||
|
|
|
|
|
|Complete
| ||SP
|10/15/2022||SG
|
|
|SP (prior AE)
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||Sohini Anand
|8/31/2021
|9/15/2021
|PENDING
| ||SG
|
|
|SP (prior AE)
|-
|-
|         POEMS Syndrome||Disease||Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
|-
|         TEMPI Syndrome||Disease||Sohini Anand, MBBS
|
|
| ||SP
|
|
|?PENDING
| ||SG
|
|
|SP (prior AE)
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera
|         POEMS Syndrome||Disease||
|
|
|
|
|Complete
|
|
|SG
| ||SP
|4/12/23 by FQR
|
|SP (prior AE); 2021 template added
|
|-
|         TEMPI Syndrome||Disease||
|
|
|
| ||SP
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|SP
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
Line 1,197: Line 1,184:
|
|
|Complete
|Complete
|5/28/2021||SG
|5/28/2021||SP
|
|
|
|SP (prior AE)
|-
|-
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|
|Complete
|Complete
|11/11/2020
|11/11/2020
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Follicular Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau
|Follicular Lymphoma||Disease||Ruthann Pfau
|7/28/2024
|
|
|
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE); has prior content in old template but same name in 5th edition - Rachel working on this outside of production site with new template to replace production site page later)
|-
|-
|    Testicular Follicular Lymphoma|| ||to be deleted
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|TO BE DELETED - NOT IN 5th EDITION
|-
|    In Situ Follicular Neoplasia||Disease||Rachel Burnside
|7/28/2023
|
|
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE); 2021 template added (no prior content; name to 5th edition version of In Situ Follicular B-cell Neoplasm will be changed later but Rachel working on 5th edition content in this production site)
|-
|-
|    Duodenal-Type Follicular Lymphoma||Disease||Rachel Burnside
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|7/28/2023
|
|
|
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE); 2021 template added (name same in 5th edition version and no prior content; Rachel working on 5th edition content in this production site)
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
Line 1,251: Line 1,238:
|Complete
|Complete
|8/16/2020
|8/16/2020
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
Line 1,259: Line 1,246:
|9/30/20
|9/30/20
|Complete
|Complete
|5/26/2021||SG
|5/26/2021||SP
|
|
|
|SP (prior AE)
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|
|Complete
|PENDING
|09/10/2022
| ||SP
|SG
|
|
|
|SP (prior AE)
|-
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
Line 1,277: Line 1,263:
|PENDING
|PENDING
|
|
|SG
|SP
|
|
|
|SP (prior AE)
|-
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Tsigab Hagos (trainee)/Shashirekha.Shetty
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|12/19/2022
|1/19/2022
|Pending
|
|
|SG
|
|
|SP (prior AE)
|-
|    In Situ Mantle Cell  Neoplasia||Disease||Rina Kansal, MD
|6/12/22
|
|
|Complete
|7/26/2022
|SG
|
|
|SP (prior AE); 2021 template added
|SP
|-
|
| || ||
|
|-
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|SP
|
|
|-
| || ||
|
|
|
|
Line 1,314: Line 1,300:
|Greg Corboy (GC)
|Greg Corboy (GC)
|
|
|Requested to update 14022022
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
Line 1,324: Line 1,310:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|26/10/2021
|
|26/1/2022
|
|Complete
|
|03/28/22||GC
| ||GC
|03/28/22
|
|2021 template added
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
Line 1,380: Line 1,366:
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||Mary Haddadin
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|9/5/2023
|
|
|PENDING
| ||GC
|
|
|2021 template added
|-
|Intravascular Large B-cell Lymphoma||Disease||Kate Berry, Greg Corboy
|25/01/2022
|25/4/2022
|Complete
|9/1/22||GC
|9/1/22
|Emailed 28/3/2022 for progress update
|-
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando (fellow), Fabiola Quintero-Rivera
|
|
| ||GC
|
|
|PENDING
| ||GC
|
|
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).  2021 template added. FQR emailed Manando on 4/12/23
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|Complete
| ||GC
| ||GC
|28/03/2022
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease||
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
Line 1,420: Line 1,390:
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|
|
|
|Complete
| ||GC
| ||GC
|
|
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||Sudha Arumugam
|Primary Effusion Lymphoma||Disease||
|10/26/2021
|
|1/26/2022
|
|Complete
|24/01/2022||GC
|24/01/2022
|2021 template added
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
|
|
|Emailed 28/3/2022 for progress update
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
| ||GC
|
|
|Emailed 28/3/2022 for progress update
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|06/28/2021
|Complete
|28/06/2021||GC
|28/06/2021
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||Lauren Shealy (trainee), Daynna Wolff
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|10/13/21
|01/13/2022
|Complete
|27/01/2022
|GC
|27/01/2021
|2021 template added
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
Line 1,477: Line 1,414:
|
|
|-
|-
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||Kate Berry, Greg Corboy
|   Multicentric Castleman Disease||Disease||
|30/05/21
|30/08/21
|Complete
|24/02/2022||GC
|24/02/2022
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Aiko Otsubo, Holli Drendel
|7/30/21
|10/30/21
|Complete
|15/11/2021
|GC
|16/11/2021
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,502: Line 1,422:
|
|
|-
|-
| || ||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||Sumi Kitahara (SK)
| ||GC
|
|
|
|SP (prior AE)
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|
|PENDING
| ||GC
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|PENDING
| ||SK
|
|SP (prior AE)
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
| ||GC
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|?PENDING
| ||SK
|
|
|SP (prior AE)
| ||GC
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
| ||SK
|
|
|SP (prior AE)
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
| ||GC
|
|
|Complete
|11/21/2021||SK
|
|
|SP (prior AE)
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
| ||GC
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||SK
| ||GC
|
|
|
|SP (prior AE)
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
| || ||
|
|
|
|
|
| ||
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|?PENDING
| ||SK
|
|
|SP (prior AE)
| ||Snehal Patel (SP)
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|PENDING
| ||SP
|
|
| ||SK
|
|
|SP (prior AE)
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|PENDING
| ||SP
|
|
|Complete
|9/26/2022
|SK
|
|
|SP (prior AE)
|-
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|PENDING
| ||SP
|
|
|Complete
|1/21/2021
|SK
|
|
|SP (prior AE)
|-
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
|
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''||
|
|
|
|
| ||SP
|
|
|Complete
|9/26/2022
|SK
|
|
|SP (prior AE)
|-
|-
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
| ||SP
|
|
|Complete
|1/21/2021
|SK
|
|
|SP (prior AE)
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||SK
| ||SP
|
|
|SP (prior AE)
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|-
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee)
|
|
| ||SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|PENDING
| ||SK
|
|SP (prior AE)
|-
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
|
|
| ||SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
|
|
| ||SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|
|SP (prior AE)
|SP
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|
|
|PENDING
|-
| ||SK
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP (prior AE)
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|Complete
|1/21/2021
|SP
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
|-
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|PENDING
| ||SK
|
|
|SP (prior AE)
|SP
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Bo Hong
|
|
|
|
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
| ||SK
|
|
|SP (prior AE); 2021 template added
|PENDING
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|SP
|
|
|
|
| ||SK
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP (prior AE)
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau, Sara Akhavanfard (trainee)
|7/28/2023
|
|
|PENDING
|PENDING
|
|
|SK
|SP
|
|
|
|SP (prior AE); (has prior content and name will change in 5th edition - Rachel working on this outside of production site to be replaced later by Nodal TFH Cell Lymphoma, Angioimmunoblastic-Type)
|-
|-
|    Follicular T-cell Lymphoma||Disease||Rachel Burnside
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|7/28/2023
|
|
|PENDING
|
|
|SK
|Complete
|1/21/2021
|SP
|
|
|
|SP (prior AE); 2021 template added (name to 5th edition version of Nodal TFH Cell Lymphoma, Follicular-Type will be changed later but Rachel working on 5th edition content in this production site)
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
|PENDING
| ||SK
|
|
|SP (prior AE)
| ||SP
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara / Miguel Gonzalez (trainee)
|
|
|
|
|Completed
|-
|09/23/2022
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|SK
|
|
|SP (prior AE)
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara  / Miguel Gonzalez (trainee)
|
|
|PENDING
| ||SP
|
|
|Completed
|09/23/2022
|SK
|
|
|SP (prior AE)
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|
|SK
|
|
|SP (prior AE)
|-
|-
| || ||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||SP
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|    Lymphomatoid  Papulosis||Disease||
|
|
|
|
|
|
| ||Greg Corboy (GC)
| ||SP
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||Thomas Harrington (resident) + Daynna Wolff
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|06/22/2022
|09/22/2022
|PENDING
| ||GC
|
|
|2021 template added, Daynna organising
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
| ||GC
|
|
|
|
|-
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||Xiaolin (Lynn) Hu
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
|Completed
|03/21/22||GC
|03/21/22
|Edits sent 14022022
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
| ||SP
|
|
|PENDING
| ||GC
|
|
|2021 template added
|-
|-
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|PENDING
| ||GC
|
|
|2021 template added
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
| ||SP
|
|
|PENDING
| ||GC
|
|
|2021 template added
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
| ||SP
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|11/2/21
|02/02/22
|Completed
|03/21/22
|GC
|03/21/22
|2021 template added
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
| ||SP
|
|
|
|
|-
|-
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||GC
| ||SP
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Ania Shestakova (trainee) + Fabiola Quintero-Rivera
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|completed
| ||SP
|april 2022
|
|GC
|26/4/2022
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
| ||SP
|
|
|
|
|-
|-
|          Monomorphic B-cell PTLD||Disease||
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|    Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|Complete
|10/01/2021
|GC
|10/01/2021
|Xinjie Xu
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
| || ||
|
|
|
|
|
|
| ||GC
| ||
|
|
|
|
|-
|-
|   Langerhans Cell  Histiocytosis||Disease||Malaika Perchard, Greg Corboy
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|02/01/2022
|
|05/01/2022
|
|Complete
|
|04/28/2022||GC
| ||Greg Corboy (GC)
|5/19/2022
|
|
|-
|   Langerhans Cell  Sarcoma||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|Complete
|04/28/2022||GC
|5/19/2022
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,012: Line 1,825:
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
Line 2,020: Line 1,833:
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,028: Line 1,841:
|
|
|-
|-
|    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,036: Line 1,849:
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,044: Line 1,857:
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 2,052: Line 1,865:
|
|
|-
|-
|Erdheim-Chester Disease||Disease||Prashant Deshpande
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|02/02/2022
|05/02/2022
|PENDING
| ||GC
|
|
|emailed 28/3/2022 to get update
|-
| || ||
|
|
|
|
|
| ||GC
| ||
|
|
|
|
|-
|-
| || ||
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|
|
| ||
|GC
|
|
|
|
|-
|-
| || ||
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|}<br />
==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
{| class="wikitable"
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
|          Monomorphic  B-cell PTLD||Disease||
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
|
|
|Alanna Church
| ||GC
|
|
|
|
|-
|-
|}<br />
|          Monomorphic  T/NK-cell PTLD||Disease||
 
|
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
|
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Astrocystoma, IDH-Mutant
|Disease
|Meenakshi Mehrotra
|6/25/2023
|
|
|PENDING
| ||GC
|
|
|Laveniya Satgunaseelan (LS)
|
|
|2021 template added
|-
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|6/7/2022
|
|
|
|
|COMPLETE
| ||GC
|
|
|LS
|
|
|2021 template added
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
|
|PENDING
|
|
|LS
| ||GC
|
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|6/27/2023
|
|
|PENDING
|
|
|LS
|
|
|2021 template added (page created 6/27/23)
| ||GC
|-
|Angiocentric Glioma||Disease||
|
|
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
|
|-
|Diffuse Low-Grade Glioma,  MAPK Pathway-Altered||Disease||
|
|
| ||GC
|
|
|
|
|-
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Diffuse Midline Glioma, H3  K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
|PENDING
|
|
|LS
| ||GC
|
|
|
|2021 template added
|-
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|Interdigitating Dendritic Cell Sarcoma||Disease||
|2/21/2022
|
|
|COMPLETE
|
|
|LS
|
|
|2021 template added
| ||GC
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
|10/28/2022
|
|
|COMPLETE
|
|
|LS
|
|2021 template added
|-
|-
|Infant-Type Hemispheric Glioma||Disease||
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
|
| ||GC
|
|
|
|
|2021 template added
|-
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|9/13/2022<br />
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
| ||GC
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|
|
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|LS
|
|
|2021 template added
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
| || ||
|
|
|
|
|-
|
|Chordoid Glioma||Disease||
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Astroblastoma, MN1-Altered||Disease||
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|6/30/2022
|
|
|COMPLETE
| ||
|
|
|LS
|
|
|2021 template added
|-
|-
|Gangliocytoma||Disease||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
|-
| ||
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
|-
| ||
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Central Neurocytoma||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Extraventricular Neurocytoma||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Cerebellar Liponeurocytoma||Disease||
| || ||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Supratentorial Ependymoma||Disease||
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|
|}
|
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Spinal Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|
|
|
|
|
|
|
|-
|Myxopapillary Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Subependymoma||Disease||
|
|
|
|
|
|
|
|-
|Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Choroid Plexus Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
|
|
|
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Neuroepithelial Tumour||Disease||
|
|
|
|
|
|
|
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|
|
|
|
|
|
|
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|
|
|
|
|
|
|
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|
|
|
|
|
|
|
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|
|
|
|
|
|
|
|-
|Pineocytoma||Disease||
|
|
|
|
|
|
|
|-
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Pineoblastoma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Tumour of the Pineal Region||Disease||
|
|
|
|
|
|
|
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Perineurioma||Disease||
|
|
|
|
|
|
|
|-
|Hybrid Nerve Sheath Tumours||Disease||
|
|
|
|
|
|
|
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|
|-
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
|
|
|
|
|
|-
|Meningioma||Disease||
|
|
|
|
|
|
|
|-
|Solitary Fibrous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
|
|
|
|-
|Haemangioblastoma||Disease||
|
|
|
|
|
|
|
|-
|Rhabdomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|CIC-Rearranged Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Ewing Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Chordoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|
|
|
|
|
|
|
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|
|
|
|
|
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|MALT Lymphoma of the Dura||Disease||
|
|
|
|
|
|
|
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|MS
|
|2021 template added
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
|
|-
|Rosai-Dorfman Disease||Disease||
|
|
|
|
|
|
|
|-
|Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
|
|
|-
|Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Germ Cell Tumours of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Adamantinomatous Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|
|
|
|
|
|
|
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Pituitary Blastoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Meninges||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Neurofibromatosis Type 2||Disease||
|
|
|
|
|
|
|
|-
|Schwannomatosis||Disease||
|
|
|
|
|
|
|
|-
|Von Hippel-Lindau Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Tuberous Sclerosis||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
|8/22/2023
|
|PENDING
|
|LS/MS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Carney Complex||Disease||
|
|
|
|
|
|
|
|-
|DICER1 Syndrome||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Familial Paraganglioma Syndromes||Disease||
|
|
|
|
|
|
|
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Familial Retinoblastoma||Disease||
|
|
|
|
|
|
|
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Fanconi Anaemia||Disease||
|
|
|
|
|
|
|
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|}<br />
==WHO Classification of Tumours of the Breast (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|Usual Ductal Hyperplasia
|Disease
|
|
|
|
|
|-
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|
|
|
|
|
|
|
|-
|Atypical Ductal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Sclerosing Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Apocrine Adenosis and Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Microglandular Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Radial Scar/Complex Sclerosing Lesion||Disease||
|
|
|
|
|
|
|
|-
|Tubular Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Lactating Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Ductal Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Pleomorphic Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Malignant Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Intraductal Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Encapsulated Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|
|
|
|
|
|
|
|-
|Invasive Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Lobular Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Lobular Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Breast Carcinoma of No Special Type||Disease||
|
|
|
|
|
|
|
|-
|Microinvasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive lobular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tubular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Cystadenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive Micropapillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma with Apocrine Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Metaplastic Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Acinic Cell Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach
|10/12/02022
|
|PENDING
|
|Hui Chen
|
|2021 template added
|-
|Secretory Carcinoma||Disease||Hui Chen
|10/12/2022
|
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|Mucoepidermoid Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Polymorphous Adenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tall Cell Carcinoma with Reversed Polarity||Disease||
|
|
|
|
|
|
|
|-
|Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Neuroendocrine Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Hamartoma||Disease||
|
|
|
|
|
|
|
|-
|Fibroadenoma||Disease||
|
|
|
|
|
|
|
|-
|Phyllodes Tumour||Disease||
|
|
|
|
|
|
|
|-
|Syringomatous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Nipple Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Paget disease of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Haemangioma||Disease||
|
|
|
|
|
|
|
|-
|Angiomatosis||Disease||
|
|
|
|
|
|
|
|-
|Atypical Vascular Lesions||Disease||
|
|
|
|
|
|
|
|-
|Postradiation Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Primary Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Nodular Fasciitis||Disease||
|
|
|
|
|
|
|
|-
|Myofibroblastoma||Disease||
|
|
|
|
|
|
|
|-
|Desmoid Fibromatosis||Disease||
|
|
|
|
|
|
|
|-
|Inflammatory Myofibroblastic Tumour||Disease||
|
|
|
|
|
|
|
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Granular Cell Tumour||Disease||
|
|
|
|
|
|
|
|-
|Leiomyoma||Disease||
|
|
|
|
|
|
|
|-
|Leiomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Lipoma||Disease||
|
|
|
|
|
|
|
|-
|Angiolipoma||Disease||
|
|
|
|
|
|
|
|-
|Liposarcoma||Disease||
|
|
|
|
|
|
|
|-
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|
|
|
|
|
|
|
|-
|Follicular Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Burkitt Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Gynaecomastia||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Breast||Disease||
|
|
|
|
|
|
|
|-
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Ataxia-Telangiectasia||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|
|
|
|
|
|
|
|-
|CDH1-Associated Breast Cancer||Disease||
|
|
|
|
|
|
|
|-
|PALB2-Associated Cancers||Disease||
|
|
|
|
|
|
|
|-
|Peutz-Jeghers Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Polygenic Component of Breast Cancer Susceptibility
|Disease
|
|
|
|
|
|
|
|
|-
|}<br />
==Genetic Tumour Syndromes (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Constitutional Mismatch Repair Deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)||Disease||Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|Named based on GTS5 book
|-
|DICER1-Related Tumour Predisposition Syndrome (DICER1)
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|Named based on GTS5 book
|-
|Neurofibromatosis Type 1 (NF1)
|Disease
|Ngoni Faya (trainee) + Madina Sukhanova
|7/12/2023
|
|PENDING
|
|Madina Sukhanova (Madina S)
|
|Named based on GTS5 book
|-
|Familial Adenomatous Polyposis (APC)
|Disease
|Jennifer Laffin
|8/20/2023
|
|PENDING
|
|
|
|Named based on GTS5 book
|-
|}<br />
 
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
{| class="wikitable sortable"
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Gene'''
!'''Author'''
!'''Author'''

Revision as of 12:28, 28 May 2021

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myeloproliferative Neoplasms (MPN) Overview Mark Evans (trainee), Fabiola Quintero-Rivera complete Fabiola Quintero-Rivera (FQR)
    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive Disease Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera complete FQR
    Chronic Neutrophilic Leukemia (CNL) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera complete FQR
    Polycythaemia Vera (PV) Disease Gokce A. Toruner complete FQR
    Primary Myelofibrosis (PMF) Disease T. Niroshi Senaratne complete FQR 8/4/2020 before submission
    Essential Thrombocythaemia (ET) Disease Rebecca Smith (trainee) + Fabiola Quintero-Rivera complete/pending faculty review FQR
    Chronic Eosinophilic Leukemia, Not Otherwise Specified Disease (trainee), Daynna J.Wolff pending faculty review FQR
    Myeloproliferative Neoplasm (MPN), Unclassifiable Disease Thomas Lee 8/17/2020 9/7/2020 complete FQR
Mastocytosis Overview Shashi Shetty, Ph.D. complete FQR
    Cutaneous Mastocytosis Disease Thuy Phung/Shuo-Shawn Liu complete/pending adding content online as of 2/4/21 FQR
    Systemic Mastocytosis Disease Shashi Shetty complete FQR
    Mast Cell Sarcoma Disease Thuy Phung +Jordan Lowery complete FQR
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 Overview Daynna J.Wolff complete FQR
    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Disease Jay Alden (trainee) +Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Disease Christopher Sullivan (trainee) + Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Disease Yanna Ding Complete FQR
    Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Disease Jessica Snider (trainee) + Daynna J.Wolff Complete FQR
Myeloid/Lymphoid Neoplasms with ETV6-JAK2 Disease Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myeloid/Lymphoid Neoplasms with BCR-JAK2 Disease Lauren R. Crowson (trainee) + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) Overview Linsheng Zhang Complete FQR
    Chronic Myelomonocytic Leukemia (CMML) Disease Linsheng Zhang Complete FQR
    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative Disease Linsheng Zhang Complete FQR
    Juvenile Myelomonocytic Leukemia (JMML) Disease Sarah Rapisardo 9/1/20 PENDING FQR
    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera complete FQR
    Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable Disease Ruth MacKinnon complete FQR
Myelodysplastic Syndromes (MDS) Overview Teresa Smolarek? 9/1/20 pending FQR
    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia Disease Xiaoli Du(trainee) +Teresa Smolarek 9/1/20 PENDING FQR
    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia Disease Xiaoli Du(trainee)+Teresa Smolarek 9/1/20 PENDING FQR
    Myelodysplastic Syndrome (MDS) with Excess Blasts Disease Xiaoli Du(trainee)+Teresa Smolarek 9/1/20 PENDING FQR
    Myelodysplastic Syndrome (MDS) with Isolated del(5q) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS), Unclassifiable Disease Xiaolin Hu(trainee)+Teresa Smolarek complete FQR
    Refractory Cytopenia of Childhood Disease Xiaoli Du(trainee)+Teresa Smolarek 9/1/20 PENDING FQR
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms Overview Daynna Wolff+Daniel Butler (Path Resident) Complete Jennelle Hodge (JH)/ Malini Sathanoori (MS) 04/26/2021 -MS (re-review)
Myeloid Neoplasms with Germline Predisposition Overview Ying Zou Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukaemia with Germline CEBPA Mutation Disease Daynna Wolff+Matthew Kilpatrick (Path Resident) PENDING JH / MS 04/26/2021 -MS (re-review)
    Myeloid Neoplasms with Germline DDX41 Mutation Disease Fei Yang Complete JH / MS 03/01/2021-MS
    Myeloid Neoplasms with Germline RUNX1 Mutation Disease Malini Sathanoori Complete 02/03/2021 JH / MS
    Myeloid Neoplasms with Germline ANKRD26 Mutation Disease Fei Yang Complete JH / MS 03/02/2021-MS
    Myeloid Neoplasms with Germline ETV6 Mutation Disease Ying Zou Complete JH / MS 03/02/2021-MS (re-review)
    Myeloid Neoplasms with Germline GATA2 Mutation Disease Daynna Wolff+ Alexandria Avery (Path Resident) Complete JH / MS 04/26/2021 -MS (re-review)
Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities Overview Daynna Wolff+ Dan Wang (trainee) Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Disease Christine Bryke Complete JH / MS 04/26/2021-MS (re-review)
    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Disease Christine Bryke Complete JH / MS 03/01/2021-MS (re-review)
    Acute Promyelocytic Leukemia (APL) with PML-RARA Disease Shashi Shetty Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 Disease Shashi Shetty Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 Disease Jennelle Hodge Complete JH / MS 02/24/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM Disease Gordana Raca Complete JH / MS Need permission for figure? Update WHO?
    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with BCR-ABL1 Disease Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated NPM1 Disease Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS Add WHO reference
    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA Disease Paul deFazio, MSc + Greg Conboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated RUNX1 Disease Daynna Wolff+Iris Martin (Path Resident) Complete JH / MS
Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Disease Fei Yang Complete JH / MS
Therapy-Related Myeloid Neoplasms Disease Shashi Shetty + Shawn A. Silver (resident) Complete JH / MS Check reference format
Acute Myeloid Leukemia (AML), Not Otherwise Specified Overview Anwar Iqbal Complete JH / MS
    Acute Myeloid Leukemia (AML) with Minimal Differentiation Disease Fabiola Quintero-Rivera and Celeste Eno (fellow) Complete JH / MS
   Acute Myeloid Leukemia (AML) without Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myelomonocytic Leukemia Disease Fei Yang Complete JH / MS
    Acute Monoblastic and Monocytic Leukemia Disease Fei Yang Complete JH / MS
    Pure Erythroid Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Megakaryoblastic Leukemia (AMKL) Disease Fei Yang Complete JH / MS
    Acute Basophilic Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Panmyelosis with Myelofibrosis Disease Ying Zou and Jialing Huang (MGP fellow) Complete JH / MS
Myeloid Sarcoma Disease Fabiola Quintero-Rivera Complete JH / MS
Myeloid Proliferations Associated with Down Syndrome Overview Patty Greipp Complete JH / MS Need permission for figure?
    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
    Myeloid Leukemia Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
Blastic Plasmacytoid Dendritic Cell Neoplasm Disease Daynna Wolff+Hao Liu (Path Resident) Complete JH / MS
Acute Leukemias of Ambiguous Lineage Overview Hui Chen/ Jennelle Hodge Complete JH / MS
    Acute Undifferentiated Leukemia Disease Shashi Shetty + Amelia Nakanishi (resident) Complete JH / MS Check reference format
    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified Disease Shashi Shetty + Priyatharsini Nirmalanantham (resident) Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified Disease Fabiola Quintero-Rivera Complete JH / MS
    Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types Disease Daynna Wolff+ Elicia Goodale (resident) PENDING JH / MS
    Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS) Disease Daynna Wolff+Madison Hannay or Elicia Goodale (residents) PENDING JH / MS
Acute Myeloid Leukemia (AML) with Mutated FLT3 Disease Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with NUP214-ABL1 Disease Daynna Wolff+Jessica Snider (Path Resident) PENDING JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 Disease Daynna Wolff+ Paige Woodham (Path Resident) PENDING JH / MS NON-WHO ENTITY
Precursor Lymphoid Neoplasms Overview Yassmine Akkari (YA)
B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Overview YA
    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1     Disease Afia Hasnain + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged Disease Yassmine Akkari+Nicolas Millan (trainee) PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 Disease Marilena Melas + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy Disease Afia Hasnain + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy Disease Ashwini Yenamandra +

Lisa Smith + Yassmine Akkari

Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 Disease Binu Porath + Linda Cooley PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 Disease Binu Porath + Linda Cooley PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like Disease Mark G. Evans + Fabiola Quintero-Rivera Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with iAMP21 Disease Holli Drendel PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified Disease Holli Drendel PENDING YA
B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 Disease Diana Rush PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 Disease Celeste Eno PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements Disease Marilena Melas PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions Disease Chenkai Ma PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) Disease Celeste Eno PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) Disease Alaa Koleilat PENDING YA NON-WHO ENTITY
T-Lymphoblastic Leukemia/Lymphoma Overview Fei Yang PENDING YA
Early T-Cell Precursor Lymphoblastic Leukemia Disease Fei Yang PENDING YA
NK-Lymphoblastic Leukemia/Lymphoma Disease Fei Yang PENDING YA
Mature B-Cell Neoplasms Overview Snehal Patel (SP)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Disease SP
       Monoclonal B-cell Lymphocytosis Disease SP
B-cell Prolymphocytic Leukemia Disease SP
Splenic Marginal Zone Lymphoma Disease Snehal Patel Complete SP
Hairy Cell Leukemia Disease Snehal Patel Complete SP
Splenic B-cell Lymphoma/Leukemia, Unclassifiable Overview Snehal Patel Complete SP
    Splenic Diffuse Red Pulp Small B-cell Lymphoma Disease Snehal Patel Complete SP
    Hairy Cell Leukemia Variant Disease Snehal Patel Complete SP
Lymphoplasmacytic Lymphoma Disease SP
   Waldenstrom Macroglobulinemia Disease SP
IgM Monoclonal Gammopathy of Undetermined Significance Disease SP
Heavy Chain Diseases Overview SP
    Mu Heavy Chain Disease Disease SP
   Gamma Heavy Chain Disease Disease Manisha Sutariya Complete 5/26/2021 SP
    Alpha Heavy Chain Disease Disease SP
Plasma Cell Neoplasms Overview Zhenya Tang PENDING SP
   Non-IgM Monoclonal Gammopathy of Undetermined Significance Disease Zhenya Tang PENDING SP
    Plasma Cell Myeloma Disease Zhenya Tang/Huang Mo (trainee) PENDING SP
    Plasma Cell Myeloma Variants Disease Fariborz Rashid-Kolvear PENDING SP
    Plasmacytoma Disease Zhenya Tang PENDING SP
    Monoclonal Immunoglobulin Deposition Diseases Overview SP
           Primary Amyloidosis Disease SP
           Light Chain and Heavy Chain Deposition Disease Disease SP
Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome Overview SP
         POEMS Syndrome Disease SP
         TEMPI Syndrome Disease SP
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) Disease Whayoung Lee, trainee)/Fabiola Quintero-Rivera 3/9/21 PENDING SP
Nodal Marginal Zone Lymphoma Disease Shivani Golem Complete 5/28/2021 SP
    Paediatric Nodal Marginal Zone Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) Complete 11/11/2020 SP
Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    Testicular Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    In Situ Follicular Neoplasia Disease Ruthann Pfau PENDING SP
    Duodenal-Type Follicular Lymphoma Disease Ruthann Pfau PENDING SP
Paediatric-Type Follicular Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) Complete 8/16/2020 SP
Large B-cell Lymphoma with IRF4 Rearrangement Disease Afia Hasnaid 9/30/20 Complete 5/26/2021 SP
Primary Cutaneous Follicle Centre Lymphoma Disease Shivani Golem PENDING SP
Mantle Cell Lymphoma Disease Mahsa Khanlari 8/15/20 PENDING SP
    Leukemic Non-Nodal Mantle Cell Lymphoma Disease SP
    In Situ Mantle Cell Neoplasia Disease SP
Diffuse Large B-cell Lymphoma, Not Otherwise Specified Disease Ashwini Yenamandra PENDING Greg Corboy (GC)
T-cell/Histiocyte-Rich Large B-cell Lymphoma Disease GC
Primary Diffuse Large B-cell Lymphoma of the CNS Disease GC
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type Disease GC
EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
EBV-Positive Mucocutaneous Ulcer Disease GC
Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation Disease GC
    Fibrin-Associated Diffuse Large B-cell Lymphoma Disease GC
Lymphomatoid Granulomatosis Disease GC
Primary Mediastinal (Thymic) Large B-cell Lymphoma Disease GC
Intravascular Large B-cell Lymphoma Disease GC
ALK-Positive Large B-cell Lymphoma Disease GC
Plasmablastic Lymphoma Disease Mark Evans (trainee), Fabiola Quintero-Rivera Complete GC
Primary Effusion Lymphoma Disease GC
HHV8-Associated Lymphoproliferative Disorders Overview GC
   Multicentric Castleman Disease Disease GC
   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
   HHV8-Positive Germinotropic Lymphoproliferative Disorder Disease GC
Burkitt Lymphoma Disease Becky Leung (trainee), Greg Corboy 3/11/21 PENDING GC
Burkitt-Like Lymphoma with 11q Aberration Disease GC
High-Grade B-cell Lymphoma Overview GC
    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Disease GC
    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma Disease GC
Mature T- and NK-cell Neoplasms Overview Snehal Patel (SP)
T-cell Prolymphocytic Leukemia Disease Michelle Don PENDING SP
T-cell Large Granular Lymphocytic Leukemia Disease Michelle Don PENDING SP
Chronic Lymphoproliferative Disorder of NK Cells Disease Michelle Don PENDING SP
Aggressive NK-cell Leukemia Disease SP
EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood Overview SP
  Systemic EBV-Positive T-cell Lymphoma of Childhood Disease Lisa Lansdon (trainee) PENDING SP
   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form Disease SP
    Hydroa Vacciniforme-Like Lymphoproliferative Disorder Disease SP
    Severe Mosquito Bite Allergy Disease SP
Adult T-cell Leukemia/Lymphoma Disease SP
Extranodal NK/T-cell Lymphoma, Nasal Type Disease SP
Intestinal T-cell Lymphoma Overview Sumire Kitahara, Derick Okwan (trainee) PENDING SP
    Enteropathy-Associated T-cell Lymphoma Disease Sumire Kitahara, Derick Okwan (trainee) Complete 1/21/2021 SP
     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Disease Sumire Kitahara PENDING SP
     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
Hepatosplenic T-cell Lymphoma Disease Michelle Don Complete 1/21/2021 SP
Subcutaneous Panniculitis-Like T-cell Lymphoma Disease SP
Mycosis Fungoides Disease Daynna Wolff, Jane Scribner (trainee) PENDING SP
Sézary Syndrome Disease Daynna Wolff, Madison Hannay (trainee) PENDING SP
Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders Overview SP
    Lymphomatoid Papulosis Disease SP
    Primary Cutaneous Anaplastic Large Cell Lymphoma Disease SP
Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes Overview SP
     Primary Cutaneous Gamma Delta T-cell Lymphoma Disease SP
     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Disease SP
     Primary Cutaneous Acral CD8+ T-cell Lymphoma Disease SP
     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder Disease SP
Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS) Disease SP
Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin Overview SP
     Angioimmunoblastic T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
    Follicular T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype Disease Hans Hamnvåg PENDING SP
Anaplastic Large Cell Lymphoma, ALK-Positive Disease Sumire Kitahara PENDING SP
Anaplastic Large Cell Lymphoma, ALK-Negative Disease Sumire Kitahara PENDING SP
Breast Implant-Associated Anaplastic Large Cell Lymphoma Disease Sumire Kitahara PENDING SP
Hodgkin Lymphomas Overview Greg Corboy (GC)
Nodular Lymphocyte Predominant Hodgkin Lymphoma Disease GC
Classic Hodgkin Lymphoma Overview GC
    Nodular Sclerosis Classic Hodgkin Lymphoma Disease GC
    Lymphocyte-Rich Classic Hodgkin Lymphoma Disease GC
    Mixed Cellularity Classic Hodgkin Lymphoma Disease GC
    Lymphocyte-Depleted Classic Hodgkin Lymphoma Disease GC
Immunodeficiency-Associated Lymphoproliferative Disorders Overview GC
Lymphomas Associated with HIV Infection Disease GC
Post-Transplant Lymphoproliferative Disorders Overview GC
    Non-Destructive Post-Transplant Lymphoproliferative Disorders Disease GC
    Polymorphic Post-Transplant Lymphoproliferative Disorders Disease Anna Shestakova (trainee)+,

Fabiola Quintero-Rivera

PENDING GC
    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) Overview GC
          Monomorphic B-cell PTLD Disease GC
          Monomorphic T/NK-cell PTLD Disease GC
    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Disease GC
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders Disease GC
Histiocytic and Dendritic Cell Neoplasms Overview GC
Histiocytic Sarcoma Disease GC
Tumors Derived From Langerhans Cells Overview GC
   Langerhans Cell Histiocytosis Disease GC
   Langerhans Cell Sarcoma Disease GC
Indeterminate Dendritic Cell Tumour Disease GC
Interdigitating Dendritic Cell Sarcoma Disease GC
Follicular Dendritic Cell Sarcoma Disease GC
    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma Disease GC
Fibroblastic Reticular Cell Tumor Disease GC
Disseminated Juvenile Xanthogranuloma Disease GC
Erdheim-Chester Disease Disease GC
Gene-Specific Pages
Gene Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
BCR Brian Davis Complete 8/10/18
ABL1 Brian Davis Complete 4/16/19
RUNX1 Brian Davis Complete 6/9/19
RUNX1T1 Brian Davis Complete 5/23/19
MYH11 Brian Davis Complete 8/6/18
FLT3 Kay Weng Choy Complete
NPM1 Kay Weng Choy Complete
TP53 Kay Weng Choy Complete
DNMT3A Kay Weng Choy Complete
CEBPA Gordana Complete
IDH1 Paul De Fazio Complete
IDH2 Paul De Fazio Complete
PML Brian Davis Complete 12/5/18
RARA Brian Davis Complete 8/3/18
ETV6 Brian Davis Complete 6/9/19
KIT Brian Davis Complete 10/1/18
CBFB Brian Davis Complete 8/2/18
GATA2 Kay Weng Choy Complete
PTEN Beth Pitel Pending
MLTT3
MECOM Brian Davis Pending
FGFR1(FLT2) Brian Davis Pending
KMT2A
DEK Wahab A. Khan Pending
NUP214 Wahab A. Khan Pending
RBM15
MKL1
DDX41 Ying Zou 8/7/20 Pending
ANKRD26
CUX1
TET2
EZH2
FOXP1
MYC
JAK2
WT1 DONE DONE
CBL
NF1
SUZ12
ERG
EST2
RPS14
RB1
MPL
CHGA
CDH1
SRSF2
DNMT1
PRDX2
ASXL1 DONE DONE
MN1
SF3A1
EP300
JARID2
BRCA1
BRCA2
Retrieved from "https://content.ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=10289"